Skip Navigation


Annals of Oncology Advance Access originally published online on April 27, 2005
Annals of Oncology 2005 16(8):1399; doi:10.1093/annonc/mdi232
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
16/8/1399    most recent
mdi232v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ghesquieres, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ghesquieres, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society for Medical Oncology

Letter to the Editor

Severe interstitial pneumonitis following rituximab and bleomycin-containing combination chemotherapy

The first 10% of the full text of this article appears below.

Rituximab is effective in B-cell lymphomas as a single agent or in combination with chemotherapy [1Go]. Its side-effects are generally mild but cases of severe pulmonary toxicity have recently been reported [2Go].

 We report two patients who developed severe interstitial pneumonitis after combination of rituximab with ACVBP (adriamycin, . . . [Full Text of this Article]

Case report 1

Case report 2

H. Ghesquieres*

Centre Leon Berard, 28 rue Laennec, 69008 Lyon, France

* Email: ghesquie@lyon.fnclcc.fr


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 haematolHome page
L. Nieuwenhuizen, F. J. Verzijlbergen, E. Wiltink, J. C. Grutters, and D. H. Biesma
A possible role of 18F-FDG positron-emission tomography scanning in the early detection of rituximab-induced pneumonitis in patients with non-Hodgkin's lymphoma
Haematologica, August 1, 2008; 93(8): 1267 - 1269.
[Full Text] [PDF]

Home page
 Ann OncolHome page
I. Dimopoulou, A. Bamias, P. Lyberopoulos, and M. A. Dimopoulos
Pulmonary toxicity from novel antineoplastic agents
Ann. Onc., March 1, 2006; 17(3): 372 - 379.
[Abstract] [Full Text] [PDF]